CYPHERPUNK TECHNOLOGIES INC. Investment Income, Nonoperating
CYPHERPUNK TECHNOLOGIES INC. (CYPH) reported Investment Income, Nonoperating of $63.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2026-08-12
- CYPHERPUNK TECHNOLOGIES INC. investment income, nonoperating for the quarter ending 2026-06-30 was $63.00K, a 74.39% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. investment income, nonoperating for the quarter ending 2026-03-31 was $95.00K, a 78.26% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. investment income, nonoperating for the quarter ending 2025-12-31 was $110.00K, a 81.51% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. investment income, nonoperating for the quarter ending 2025-09-30 was $123.00K, a 86.24% decline year-over-year.
- CYPHERPUNK TECHNOLOGIES INC. investment income, nonoperating for fiscal 2025 was $916.00K, a 70.73% decline from fiscal 2024.
- CYPHERPUNK TECHNOLOGIES INC. investment income, nonoperating for fiscal 2024 was $3.13M.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $63.00K 10-Q · filed 2026-08-12 | $158.00K 10-Q · filed 2026-08-12 | $268.00K derived: sum of 3 quarters · filed 2026-08-12 | $391.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $95.00K 10-Q · filed 2026-05-14 | $205.00K derived: sum of 2 quarters · filed 2026-05-14 | $328.00K derived: sum of 3 quarters · filed 2026-05-14 | $574.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $233.00K derived: sum of 2 quarters · filed 2026-03-16 | $479.00K derived: sum of 3 quarters · filed 2026-08-12 | $916.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $123.00K 10-Q · filed 2025-11-12 | $369.00K derived: sum of 2 quarters · filed 2026-08-12 | $806.00K 10-Q · filed 2025-11-12 | $1.40M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $246.00K 10-Q · filed 2026-08-12 | $683.00K 10-Q · filed 2026-08-12 | $1.28M derived: sum of 3 quarters · filed 2026-08-12 | $2.17M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $437.00K 10-Q · filed 2026-05-14 | $1.03M derived: sum of 2 quarters · filed 2026-05-14 | $1.93M derived: sum of 3 quarters · filed 2026-05-14 | $2.79M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.49M derived: sum of 2 quarters · filed 2026-03-16 | $2.35M derived: sum of 3 quarters · filed 2026-03-16 | $3.13M 10-K · filed 2026-03-16 |
| 2024-09-30 | $894.00K 10-Q · filed 2025-11-12 | $1.76M derived: sum of 2 quarters · filed 2025-11-12 | $2.53M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $865.00K 10-Q · filed 2025-08-14 | $1.64M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $775.00K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |